Received Feb 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
her daughter had "a really bad reaction of swelling" after receiving her first dose of GARDASIL 9; This spontaneous report was received from a receptionist and refers to her daughter, a 12-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-Mar-2025, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) (strength, dose, frequency, lot #, and expiration date were not reported) for prophylaxis. After receiving the vaccine, the patient experienced a really bad reaction of swelling. At the reporting time, the outcome of the event was not provided. The causal relationship between the event and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) was not provided. Lot # is being requested and will be submitted if received.